Artal Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$1.13M Hold
2022
Q4
$749K Hold
2022
Q3
$1.35M Hold
2022
Q2
$2.17M Hold
2022
Q1
$2.07M Hold
2021
Q4
$3.5M Hold
2021
Q3
$6.38M Hold
2021
Q2
$12.3M Hold
2021
Q1
$16.6M Buy
2020
Q4
$15.5M Hold
2020
Q3
$10.2M Buy
2020
Q2
$5.38M Sell
2020
Q1
$3.1M Hold
2019
Q4
$5.71M Sell
2019
Q3
$7.09M Sell
2019
Q2
$7.01M Hold
2019
Q1
$8.54M Buy